Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic dexamethasone after failed oral prednisolone for sudden sensorineural hearing loss
TCTR20220128003Phase 3Completed
- Sponsor
- Chaophrayayommarat Hospital Ethical Committee
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in idiopathic sudden sensorineural hearing loss (ISSNHL), sponsored by Chaophrayayommarat Hospital Ethical Committee. Started Feb 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on TCTR20220128003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220128003.